Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis

Metabolism: Clinical and Experimental

Volumn 54, Issue 3, 2005, Pages 335-344

  Clarenbach, Jacob J ^a   Lindenthal, Bernhard ^a   Dotti, Maria Theresa ^b   Federico, Antonio ^b   Kelleher, Joanne K ^c   Von Bergmann, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

^b USA   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTANOL; CHOLESTEROL; LANOSTEROL; LATHOSTEROL; PRAVASTATIN; STEROL DERIVATIVE;

ADULT; ARTICLE; BILE; BLOOD SAMPLING; CASE REPORT; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DUODENUM; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SPECTROSCOPY; VENOUS BLOOD;

EID: 13844269369     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.09.013     Document Type: Article

References (30)

1. L. van Bogaert, H.J. Scherer, and E. Epstein Une forme cerebrale de la cholesterinose generalisee 1937 Mason et Cie Paris
2. S. Skrede, I. Bjorkhem, E.A. Kvittingen, M.S. Buchmann, S.O. Lie, and C. East Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis J. Clin. Invest. 78 1986 729 735
3. G. Salen, and S.M. Grundy The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis J. Clin. Invest 52 1973 2822 2835
4. T. Setoguchi, G. Salen, G.S. Tint, and E.H. Mosbach A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain J. Clin. Invest 53 1974 1393 1401
5. B.G. Wolthers, H.T. Walrecht, J.C. van der Molen, G.T. Nagel, J.J. Van Doormaal, and P.N. Wijnandts Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis J. Lipid Res. 32 1991 603 612
6. I. Bjorkhem, T. Miettinen, E. Reihner, S. Ewerth, B. Angelin, and K. Einarsson Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver J. Lipid Res. 28 1987 1137 1143
7. H.J. Kempen, J.F. Glatz, J.A. Gevers Leuven, H.A. van der Voort, and M.B. Katan Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans J. Lipid Res. 29 1988 1149 1155
8. T.A. Miettinen, R.S. Tilvis, and Y.A. Kesaniemi Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population Am. J. Epidemiol. 131 1990 20 31
9. B. Lindenthal, A. Simatupang, M.T. Dotti, A. Federico, D. Lütjohann, and K. von Bergmann Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis J. Lipid Res. 37 1996 2193 2201
10. H. Rosen, A. Reshef, N. Maeda, A. Lippoldt, S. Shpizen, and L. Triger Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene J. Biol. Chem. 273 24 1998 14805 14812
11. -/- mice but not in cerebrotendinous xanthomatosis J. Biol. Chem. 276 37 2001 34579 34585
12. B. Goodwin, K.C. Gauthier, M. Umetani, M.A. Watson, M.I. Lochansky, and J.L. Collins Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor Proc. Natl. Acad. Sci. U. S. A. 100 1 2003 223 228
13. I. Dussault, H.D. Yoo, M. Lin, E. Wang, M. Fan, and A.K. Batta Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance Proc. Natl. Acad. Sci. U. S. A. 100 3 2003 833 838
14. M.K. Hellerstein, and R.A. Neese Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers Am. J. Physiol. 263 1992 E988 E1001
15. J.K. Kelleher, A.T. Kharroubi, T.A. Aldaghlas, I.B. Shambat, K.A. Kennedy, and A.L. Holleran Isotopomer spectral analysis of cholesterol synthesis: applications in human hepatoma cells Am. J. Physiol. 266 1994 E384 E395
16. S.M. Grundy, and A.L. Metzger A physiological method for estimation of hepatic secretion of biliary lipids in man Gastroenterology 62 1972 1200 1217
17. K. von Bergmann, M. Epple-Gutsfeld, and O. Leiss Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones Gastroenterology 87 1984 136 143
18. O. Leiss, K. Meyer-Krahmer, and K. von Bergmann Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate J. Lipid Res. 27 1986 213 223
19. G.S. Tint, B. Dayal, A.K. Batta, S. Shefer, F.W. Cheng, and G. Salen Gas-liquid chromatography-mass spectrometry of trimethylsilyl ethers of bile alcohols J. Lipid Res. 19 1978 956 966
20. J.K. Kelleher, and T.M. Masterson Model equations for condensation biosynthesis using stable isotopes and radioisotopes Am. J. Physiol. 262 1992 E118 E125
21. K. Empen, K. Lange, E.F. Stange, and J. Scheibner Newly synthesized cholesterol in human bile and plasma: quantitation by mass isotopomer distribution analysis Am. J. Physiol. 272 1997 G367 G373
22. B. Lindenthal, T.A. Aldaghlas, A.L. Holleran, T. Sudhop, H.K. Berthold, and K. Von Bergmann Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells Am. J. Physiol. Endocrinol. Metab. 282 2002 E1222 E1230
23. I. Bjorkhem, K.M. Boberg, and E. Leitersdorfer Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular basis of inherited disease 2001 McGraw-Hill Book Co New York 2961 2988
24. M. Kuriyama, Y. Tokimura, J. Fujiyama, Y. Utatsu, and M. Osame Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use J. Neurol. Sci. 125 1994 22 28
25. T. Nakamura, Y. Matsuzawa, K. Takemura, M. Kubo, H. Miki, and S. Tarui Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis Metabolism 40 1991 741 746
26. G. Salen, T.W. Meriwether, and G. Nicolau Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis Biochem. Med. 14 1975 57 74
27. G. Salen, A.K. Batta, G.S. Tint, and S. Shefer Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis Metabolism 43 1994 1018 1022
28. A. Verrips, R.A. Wevers, B.G. Van Engelen, A. Keyser, B.G. Wolthers, and F. Barkhof Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis Metabolism 48 1999 233 238
29. V.M. Berginer, G. Salen, and S. Shefer Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid N. Engl. J. Med. 311 26 1984 1649 1652
30. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, and A. Luk Identification of a nuclear receptor for bile acids Science 284 5418 1999 1362 1365